NGAL is a secreted protein and, as such, is a strong candidate to play crucial roles in tumor microenvironment given that it is released not only by cancer cells, but also by several non-neoplastic cell populations that contribute at different levels to cancer development and progression. The gene discussed is LCN2; the disease is neoplasm.